Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,116 | 44,252 | 35,277 | 88,227 | 25,218 |
| Marketable Securities | 230,636 | 210,974 | 268,339 | 416,750 | 708,737 |
| Receivables | N/A | N/A | 1,205 | 5,981 | 22,492 |
| Inventories | N/A | N/A | 16,101 | 19,202 | 15,801 |
| Other current assets | 20,514 | 6,066 | 9,779 | 15,808 | 23,333 |
| TOTAL | $266,266 | $261,292 | $330,701 | $545,968 | $795,581 |
| Non-Current Assets | |||||
| PPE Net | 2,060 | 3,411 | 18,856 | 32,451 | 60,510 |
| Investments And Advances | 3,491 | 26,087 | 25,825 | 0 | 64,828 |
| Intangibles | 0 | 0 | 0 | 76,501 | 76,501 |
| Other Non-Current Assets | 8,589 | 13,060 | 22,651 | 55,680 | 119,769 |
| TOTAL | $14,140 | $42,558 | $67,332 | $164,632 | $321,608 |
| Total Assets | $280,406 | $303,850 | $398,033 | $710,600 | $1,117,189 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,770 | 11,560 | 9,848 | 12,980 | 9,747 |
| Accrued Expenses | 22,271 | 29,972 | 22,162 | 36,557 | 42,544 |
| TOTAL | $53,536 | $61,400 | $51,269 | $68,204 | $85,200 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 137,038 | 181,713 | 215,777 | 275,758 | 352,481 |
| TOTAL | $137,038 | $181,713 | $215,777 | $275,758 | $352,481 |
| Total Liabilities | $190,574 | $243,113 | $267,046 | $343,962 | $437,681 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,688 | 12,413 | 12,247 | 12,622 | 12,424 |
| Common Shares | 2 | 1 | 19 | 19 | 19 |
| Retained earnings | -3,760,286 | -3,596,210 | -3,477,249 | -3,201,193 | -2,832,995 |
| Other shareholders' equity | 17 | 61 | 80 | -6,907 | -4,157 |
| TOTAL | $89,832 | $60,737 | $130,987 | $366,638 | $679,508 |
| Total Liabilities And Equity | $280,406 | $303,850 | $398,033 | $710,600 | $1,117,189 |